MedTrace Logo

Scaling up Trauma-Informed Outreach With People Affected by Violence - CLOE Intervention

NCT06144216 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 86

Last updated 2026-04-24

No results posted yet for this study

Summary

This mixed methods, community-based study examines the implementation and outcomes of the Community-Led Outreach and Engagement Model (CLOE) for women and youth affected by violence. Outreach services are designed to mitigate the effects of gender-based violence, build trusting relationships with service providers, and improve safety, well-being and engagement with health and social care. Over a 2-year implementation period, we will test how outreach, combined with enhanced service integration, supports participants to identify priority needs and can bridge the gap in accessible and appropriate service with people affected by violence.

Conditions

  • Gender-based Violence
  • Outreach Intervention

Interventions

OTHER

CLOE Outreach Intervention

The CLOE outreach intervention is a community-led, strengths-based, and trauma-informed program to support self-identifying women and youth who experience interpersonal and structural gender-based violence. Outreach services are designed to mitigate the effects of gender-based violence, build trusting relationships with service providers, and improve safety, well-being and engagement with health and social care.

Sponsors & Collaborators

  • Social Sciences and Humanities Research Council of Canada

    collaborator OTHER

  • Michael Smith Health Research BC

    collaborator UNKNOWN

  • University of Windsor

    collaborator OTHER

  • Dalhousie University

    collaborator OTHER

  • University of British Columbia

    lead OTHER

Principal Investigators

  • Victoria Bungay, PhD · University of British Columbia

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-21
Primary Completion
2025-12-11
Completion
2025-12-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06144216 on ClinicalTrials.gov